Duality Biotherapeutics, Inc. (9606) Income Statement

4 Followers

Duality Biotherapeutics, Inc. Income Statement

Last quarter (Q2 2025), Duality Biotherapeutics, Inc.'s total revenue was ¥614.47M, an increase of 455.46% from the same quarter last year. In Q2, Duality Biotherapeutics, Inc.'s net income was ¥-1.04B. See Duality Biotherapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25	Dec 24	Dec 23	Dec 22
Total Revenue	¥ 1.80B	¥ 1.94B	¥ 1.79B	¥ 1.60M
Gross Profit	¥ 561.85M	¥ 784.67M	¥ 1.36B	¥ 1.60M
Operating Expenses	¥ 978.11M	¥ 973.66M	¥ 577.53M	¥ 370.18M
Depreciation and Amortization	¥ 12.00M	¥ 7.87M	¥ 4.99M	¥ 1.79M
EBITDA	¥ -404.27M	¥ -1.01B	¥ -197.07M	¥ -385.22M
Operating Income	¥ -416.27M	¥ -188.99M	¥ 781.36M	¥ -368.58M
Other Income/Expenses	¥ -2.11B	¥ -825.55M	¥ -983.60M	¥ -18.51M
Pretax Income	¥ -2.53B	¥ -1.01B	¥ -202.25M	¥ -387.09M
Net Income	¥ -2.53B	¥ -1.05B	¥ -357.51M	¥ -387.09M
Per Share Metrics
Basic EPS	¥ -38.79	¥ -12.63	¥ -4.30	¥ -4.65
Diluted EPS	¥ -38.79	¥ -12.63	¥ -4.30	¥ -4.65
Weighted Average Shares Outstanding	65.16M	83.18M	83.18M	83.18M
Weighted Average Shares Outstanding (Diluted)	65.16M	83.18M	83.18M	83.18M

Currency in CNY

Duality Biotherapeutics, Inc. (9606) Income Statement

Duality Biotherapeutics, Inc. Income Statement

Duality Biotherapeutics, Inc. Earnings and Revenue History